unknown
Stage
1
Investors
About
Exogenus Therapeutics is a Portuguese biotechnology company developing exosome-based therapeutics derived from umbilical cord blood for tissue regeneration and inflammatory diseases.
Explore Exogenus Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.